These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1277 related items for PubMed ID: 18572028

  • 1. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Lev EI, Kornowski R, Vaknin-Assa H, Porter A, Teplitsky I, Ben-Dor I, Brosh D, Fuchs S, Battler A, Assali A.
    Am J Cardiol; 2008 Jul 01; 102(1):6-11. PubMed ID: 18572028
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI.
    Méndez-Eirín E, Flores-Ríos X, García-López F, Pérez-Pérez AJ, Estévez-Loureiro R, Piñón-Esteban P, Aldama-López G, Salgado-Fernández J, Calviño-Santos RA, Vázquez Rodríguez JM, Vázquez-González N, Castro-Beiras A.
    Rev Esp Cardiol (Engl Ed); 2012 Mar 01; 65(3):227-33. PubMed ID: 22281285
    [Abstract] [Full Text] [Related]

  • 3. TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions.
    Kozieradzka A, Kamiński K, Dobrzycki S, Nowak K, Musiał W.
    Kardiol Pol; 2007 Jul 01; 65(7):788-95; discussion 796-7. PubMed ID: 17694460
    [Abstract] [Full Text] [Related]

  • 4. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.
    Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, Cox DA, Turco M, Stuckey TD, Na Y, Lansky AJ, Gersh BJ, O'Neill WW, Mehran R, Stone GW.
    J Am Coll Cardiol; 2005 May 03; 45(9):1397-405. PubMed ID: 15862409
    [Abstract] [Full Text] [Related]

  • 5. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
    Kalińczuk Ł, Przyłuski J, Karcz M, Petryka J, Kaczmarska E, Bekta P, Kepka C, Kruk M, Pregowski J, Kadziela J, Deptuch T, Skwarek M, Cedro K, Ciszewski M, Debski A, Ciszewski A, Chmielak Z, Demkow M, Witkowski A, Ruzyłło W.
    Kardiol Pol; 2007 Jan 03; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
    [Abstract] [Full Text] [Related]

  • 6. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes.
    Foussas SG, Zairis MN, Lyras AG, Patsourakos NG, Tsirimpis VG, Katsaros K, Beldekos DJ, Handanis SM, Mytas DZ, Karidis KS, Tselioti PG, Prekates AA, Ambrose JA.
    Am J Cardiol; 2005 Aug 15; 96(4):533-7. PubMed ID: 16098307
    [Abstract] [Full Text] [Related]

  • 7. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolarz P, Spiewak M, Kochman J, Rudowski R, Opolski G.
    Int J Cardiol; 2007 Feb 14; 115(3):386-90. PubMed ID: 16860415
    [Abstract] [Full Text] [Related]

  • 8. Prospective validation of a modified thrombolysis in myocardial infarction risk score in emergency department patients with chest pain and possible acute coronary syndrome.
    Hess EP, Perry JJ, Calder LA, Thiruganasambandamoorthy V, Body R, Jaffe A, Wells GA, Stiell IG.
    Acad Emerg Med; 2010 Apr 14; 17(4):368-75. PubMed ID: 20370775
    [Abstract] [Full Text] [Related]

  • 9. White blood cell count adds prognostic information to the thrombolysis in myocardial infarction risk index in patients following primary percutaneous coronary intervention (ANIN Myocardial Infarction Registry).
    Kruk M, Karcz M, Przyłuski J, Bekta P, Kepka C, Kalińczuk Ł, Pregowski J, Kaczmarska E, Demkow M, Chmielak Z, Witkowski A, Ruzyłło W.
    Int J Cardiol; 2007 Apr 04; 116(3):376-82. PubMed ID: 16884793
    [Abstract] [Full Text] [Related]

  • 10. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ, Hendel RC, Nathan S, Meyer PM, Calvin JE, Klein LW.
    J Invasive Cardiol; 2003 Sep 04; 15(9):502-6. PubMed ID: 12947210
    [Abstract] [Full Text] [Related]

  • 11. Thrombolysis followed by early revascularization: an effective reperfusion strategy in real world patients with ST-elevation myocardial infarction.
    Jaffe R, Halon DA, Karkabi B, Goldstein J, Rubinshtein R, Flugelman MY, Lewis BS.
    Cardiology; 2007 Sep 04; 107(4):329-36. PubMed ID: 17268198
    [Abstract] [Full Text] [Related]

  • 12. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
    Danchin N, Coste P, Ferrières J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Guéret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou JP, Simon T, FAST-MI Investigators.
    Circulation; 2008 Jul 15; 118(3):268-76. PubMed ID: 18591434
    [Abstract] [Full Text] [Related]

  • 13. Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
    McLaughlin MG, Stone GW, Aymong E, Gardner G, Mehran R, Lansky AJ, Grines CL, Tcheng JE, Cox DA, Stuckey T, Garcia E, Guagliumi G, Turco M, Josephson ME, Zimetbaum P, Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications trial.
    J Am Coll Cardiol; 2004 Sep 15; 44(6):1215-23. PubMed ID: 15364322
    [Abstract] [Full Text] [Related]

  • 14. Influence of age on long-term outcome after emergent percutaneous coronary intervention for ST-elevation myocardial infarction.
    Hiew C, Williams T, Hatton R, Narasimhan S, O'Connor S, Baker F, McElduff P, Attia J, Collins N.
    J Invasive Cardiol; 2010 Jun 15; 22(6):273-7. PubMed ID: 20516507
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Risk scores for risk stratification in acute coronary syndromes: useful but simpler is not necessarily better.
    Yan AT, Yan RT, Tan M, Casanova A, Labinaz M, Sridhar K, Fitchett DH, Langer A, Goodman SG.
    Eur Heart J; 2007 May 15; 28(9):1072-8. PubMed ID: 17437970
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A percutaneous coronary intervention-thrombolytic predictive instrument to assist choosing between immediate thrombolytic therapy versus delayed primary percutaneous coronary intervention for acute myocardial infarction.
    Kent DM, Ruthazer R, Griffith JL, Beshansky JR, Concannon TW, Aversano T, Grines CL, Zalenski RJ, Selker HP.
    Am J Cardiol; 2008 Mar 15; 101(6):790-5. PubMed ID: 18328842
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE, Fu Y, Mahaffey KW, Todaro TG, Adams P, Westerhout CM, White HD, van 't Hof AW, Van de Werf FJ, Wagner GS, Granger CB, Armstrong PW.
    Circulation; 2008 Sep 23; 118(13):1335-46. PubMed ID: 18779444
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.